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Introduction 
Green tea is obtained from the tea plant Camellia sinensis 
Var. sinensis of the family Theaceae  and is cultivated in several 
countries around the world.1,2 Tea has been reported to contain over 
4000 active metabolites and a third of this number are polyphenols.3 Of 
the polyphenols, the flavonoid family of compounds constitutes the 
basic phenolic compounds in green tea which also contribute to the 
antioxidant activity exhibited by green tea.4 Green tea has been reported 
to exhibit cancer prevention,5 antioxidant activity,6 antimutagenic,7 and 
enzyme inhibition8,9 activities. Beneficial effects of green tea on the 
reproductive system are also emerging. Traditional cultures worldwide 
depend on herbal remedies for different conditions in pregnancy, birth 
and post-partum care.10 This therefore makes documentation of 
traditional knowledge of herbal remedies and scientific investigation 
relevant as it assists chemists and pharmacologists with starting points 
IRU³WDUJHWHG´DQDO\VLVGLVFRYHU\RIQRYHOWKHUDSLHVDQGQDWXUDOGUXJV
for the treatment of pregnancy and related issues.11 Green tea extract 
has been reported to significantly improve sperm motility, 
concentration and sperm membrane integrity after 28 days of green tea  
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extract administration.12 Though there have also been some contrary 
reports. For instance, Chandra and colleagues reported a significant 
decrease in epididymal sperm number, serum testosterone level in a 
dose-dependent manner and testicular steroidogenic enzyme activities 
in green tea extract -administered group of animals after 26 days.13 
Green tea extract has also been reported to improve oestradiol valerate-
induced polycystic ovarian syndrome in rat, which is a major cause of 
infertility. In one study, green tea was observed to regulate 
gonadotropin levels, reduce insulin resistance and body weights as well 
as improve the ovarian morphology.14,15 Similarly, a study reported the 
improvement of leiomyoma prognosis.16 There has however been no 
study showing the effect of green tea on uterine contractility despite 
reports on male reproductive parameters. The uterus provides the 
protective environment for the developing fetus and then at term with 
the onset of labour, it contracts rhythmically to expel the fetus and 
placenta.17 This, therefore, supports the study into uterine contractility 
as a female reproductive parameter that can be targeted for therapeutic 
interventions that can increase the quality of life for females and reduce 
complications of labour in the pregnant female. 
In the search for potential targets and therapies in managing 
dysfunctions of uterine contractility, this study was therefore designed 
to investigate the activity of green tea extract on uterine contractility 
and to also investigate possible mechanisms of action. This study is also 
aimed at identifying significant secondary metabolites present in green 
tea that may have contributed to the biological activities observed.  
 
 
Materials and Methods 
Green tea extraction 
Green tea bags (375 g) of the Lipton brand® (Unilever, USA) were 
obtained from a local supermarket in Benin City, Nigeria. The threads 
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of the bags were trimmed off and the bags were macerated in distilled 
water (6 L) and heated at 100oC for 5 min in order to mimic the method 
used for tea steeping prior to consumption. After 5 min heating, the 
mixture was allowed to cool and was decanted and sieved. The fluid tea 
extract was then concentrated by placing on a water bath set at 80 oC. 
The concentrate obtained was dried in an oven set at 40°C and the 
extract weight was determined to be 122.3 g (percentage yield was 
32.62% w/v). The extract was then stored in the UHIULJHUDWRU§°C) till 
needed.  
 
Animals 
Mature non-pregnant female albino mice weighing between 20-30 g 
were obtained from the Animal House Department of Pharmacology 
and Toxicology, Faculty of Pharmacy, University of Benin, Edo state, 
Nigeria. They were housed in plastic cages at an environmentally 
controlled room temperature of approximately 27 ± 5°C and lighting 
conditions. Ethical consent was obtained prior to the start of the 
experiments from the Faculty of Pharmacy Ethics Committee, 
University of Benin, Nigeria (EC/FP/016/04). The animals were 
handled as much as possible according to standards of the Public Health 
Service policy on humane care and use of Laboratory Animals.18,19 The 
animals were maintained on a standard diet of animal pellets and clean 
tap water.  
 
Contractility studies 
Tissue preparation 
Each mouse was administered 1.0 mg/kg diethylstilbestrol (DES) orally 
constituted in Tween 80 and distilled water (1:1), 24 h prior to the day 
of experiments. Dose and route of DES administration had been 
previously determined in our laboratory to effectively induce estrous20.  
On the day of the experiment, vaginal smears were obtained with the 
aid of a Pasteur pipette (0.1 mm), fixed with ethanol and stained with a 
drop of Gentian violet. The smears were then observed under a 
microscope using a X10 objective lens in order to ascertain the oestrous 
stage Animals in proestrus and oestrous stages were selected and 
humanely killed by cervical dislocation and the uterine horns were 
immediately excised and immediately placed into a petri dish 
containing previously warmed and aerated De JDORQ¶VSK\VLRORJLFDOVDOW
solution (composition in M: NaCl 154.00, NaHCO3 5.95, D-glucose 
2.78, KCl 5.63, and CaCl2·2H2O 2.05). The uterine tissues were cleaned 
of connective tissues and one horn dissected in half to obtain a segment 
of the uterine horn. Tissue lengths of approximately 1-2 mm each was 
obtained. The uterine segment was then mounted in a warmed 10 mL 
organ bath maintained at 37oC and containing an aerated physiological 
salt solution.  
 
Experimental protocol 
The uterine tissues were mounted in organ baths and equilibrated under 
resting tensions of 4.90 mN for 30-45 min or till regular contractions 
were obtained. The force and frequency of uterine contractions in the 
longitudinal muscle layers were measured using a 7003E-isometric 
force transducer (Ugo Basile, Varese, Italy) connected to a 17400 data 
capsule digital recorder with an inbuilt bridge amplifier (Ugo Basile, 
Varese, Italy).  
 
Experiment on the effect of extract on spontaneous uterine contraction 
The direct effect of cumulative concentrations of the extracts on uterine 
smooth muscle contractility was investigated. Concentration-response 
relationships were obtained using concentrations between (0.33 - 
1333.21 µg/mL). A contact time of 3 min was allowed following each 
concentration of extract administered. After each set of administration, 
the tissues were washed 3 times and a wash-out period of 10 min was 
allowed before the next administration. 
 
Experiment on the effect of extract on oxytocin-induced uterine 
contraction 
The effect of the extract on oxytocin-induced uterine contraction was 
investigated.20 Cumulative concentrations of the extract were tested in 
the presence of 60.0 pg/mL oxytocin. A contact time of 5 min was 
allowed after oxytocin administration before cumulative concentrations 
of the extract were added and a contact time of 3 min was allowed 
following each administration. 
 
 
Experiment on the effect on high potassium chloride-induced uterine 
contractility 
The effect of the extract was determined in the presence of high 
potassium chloride (KCl) (80 mM).20 KCl (80 mM) was added to the 
bath containing the uterine tissues and left in contact for 5 min and 
without washing, the effects of cumulative concentrations of the extract 
(0.014 ± 16.32 µg/mL) were determined.  
 
LC-HRFTMS identification of constituents in extract 
Liquid chromatography-high resolution Fourier Transform mass 
spectrometry (LC-HRFTMS) analysis was performed on a Dionex 
UltiMate-3000 (DIONEX, Sunnyvale, CA, USA) coupled to a 
ThermoScientific Exactive Orbitrap system (Thermo Fisher Scientific 
(Bremen) GmbH, Bremen, Germany). An ACE column C18 75 × 3.0 
mm column from Hichrom Ltd., Reading, UK was used. Parameters 
used were as previously described 21. Briefly, elution flow rate was set 
DW  ȝ/PLQ ZLWK ZDWHU $ DQG DFHWRQLWULOH % ERWK RI ZKLFK
contained 0.1% formic acid. A gradient flow starting with 10% B and 
increasing to 100% B, in 30 min was used. The mobile phase was 
maintained for 5 min at 100% B, followed by equilibration of the 
column with 10% B. The resulting data files were sliced into positive 
and negative datasets using ProteoWizard 22 prior to data mining which 
was done with the use of MZmine 2.10 23. Peak detection was 
accomplished using the centroid mass detector and a noise level of 1000 
was set. The chromatogram builder generated peak lists from the mass 
lists obtained from the previous step. The minimum time span was 0.2 
min, minimum height was 10,000, and the m/z tolerance was set to 
0.0001 m/z or 5 ppm. Chromatogram deconvolution was accomplished 
using the local minimum search algorithm with the following 
parameters: threshold (90%), search minimum in RT range (0.4 min), 
minimum relative height (5%), minimum absolute height (10,000), 
minimum ratio of peak top/edge (2), and peak duration range (0.2-5.0 
min). The peak lists were de-isotoped using the isotopic peaks grouper 
with an m/z tolerance of 0.001 m/z or 5 ppm, retention time tolerance of 
0.1 minutes (absolute), and a maximum charge of 2. The representative 
isotope was the most intense. The peak lists were then merged using the 
Alignment function. The weight for m/z and for retention time (RT) was 
20, and the RT tolerance was 5%. The aligned peak lists were gap-filled 
using the Peak Finder, with an intensity tolerance of 1% and RT 
tolerance of 0.5 min (absolute) 24. Adducts were identified, together 
with other complexes that may have formed. The chemical formulae of 
the peaks were predicted using the formula prediction tool developed 
by MZmine. ChemBioFinder version 13 (PerkinElmer Informatics, 
Cambridge, UK) was used to access hits from the database.  
 
Data analysis 
The mean frequency and amplitude were computed from contractions 
occurring at the last 3 min of the phasic contractions using the GraphPad 
Prism, (version 7.03; GraphPad software Inc, San Diego, CA, USA). 
Results were obtained as percentages of control applications 
(control=100%) where necessary and changes in force (amplitude) or 
frequency were expressed with respect to control (100%). All data 
VKRZQZHUHH[SUHVVHGDVPHDQVWDQGDUGHUURURIPHDQ6(0DQGµQ¶
represents the number of animals. Significance was evaluated using 
appropriate t-tests, and where necessary, one-way analysis of variance 
ZLWK 'XQQHWW¶VSRVW KRFDQG 3 YDOXHV   ZDV WDNHQ WR UHSUHVHQW
minimum significance in all cases. 
In datasets with sufficient data points, mean log concentration-response 
curves were analyzed by fitting data to a variable slope logistic 
equation, using the following equation values Y = Bottom + (Top-
Bottom)/(1+10^((LogIC50-X)*HillSlope)). Where Y = response which 
starts at the bottom and goes to the Top in sigmoid shape, X= logarithm 
of concentration and IC50 is the concentration that gives a response half 
way between Bottom and Top. 
 
 
Results and Discussion 
Effect of green tea extract on spontaneous uterine contraction 
The green tea extract, at concentrations used in this study, was observed 
to have an inhibitory effect on spontaneous uterine contraction at high 
concentrations (Figure 1A). An increase in tension of the uterus was 
observed at 13.22 µg/mL which was followed by decreases in 
contractility with subsequent increased concentrations (Figure 1A). The 
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inhibitory effect was not pronounced on the amplitude (Figure 1B) but 
rather on the frequency of contractions (B).  The EC50 of green tea was 
calculated for the frequency as 88.88 ± 0.35 ng/mL. 
 
Effect of green tea extract on oxytocin-induced uterine contractions 
The effect of green tea extract in the presence of an agonist, oxytocin 
(OT) was investigated (Figure 2A). Green tea had minimal effect on the 
amplitude though a slight inhibition was observed at higher 
concentrations of 133.21 and 1333.22 µg/mL (Figure 2B). However, a 
significant decrease (P < 0.001) in the frequency of OT-induced uterine 
contractions in the presence of green tea was observed which was also 
more pronounced at higher concentrations of 133.21 and 1333.22 
µg/mL (Figure 2C). 
 
Effect of green tea extract on high KCl-induced uterine contractions 
The effect of green tea extract in the presence of high KCl-induced 
uterine contraction was investigated (Figure. 3A). Green tea inhibited 
KCl-induced contraction though non-significantly (Figure 3B).  
Inhibitions were observed at concentrations of 13.22, 133.21 and 
1333.22 µg/mL (Figure 2B).  
 
Identified secondary metabolites in Green tea 
The LC-HRFTMS results and database search (using Dictionary of 
Natural Products) enabled the detection of 25 significant compounds 
(Tables 1 and 2), 23 of which were identified (Table 1) while two 
compounds were unknowns (Table 2). The identified compounds were 
observed to belong to a diverse range of phytochemical classes 
including pteridine, flavonoids, cyclitols, and coumarins, with the 
majority of detected compounds belonging to the flavonoid class (Table 
1) and ionizing in the negative mode (Figure 4).  The peak at 14.52 
detected in the positive mode was identified as a plasticizer, which was 
considered to be an artefact. 
Green tea extract produced inhibitions of uterine contractility on the 
contractility parameters investigated in this study which included the 
amplitude and frequency of uterine contractions.  
The smooth muscle layer of the uterus is constantly contracting all 
through the life of females and not limited to labour and/or delivery 
times. Contractility of the uterus takes place during the menstrual cycle 
in non-pregnant uterus (which may lead to dysmenorrhoea) and also 
during pregnancy particularly at term all of which occurs via a complex 
yet dynamic physiological phenomenon25 supporting the study on non-
pregnant uterus in this study. Dysfunction of the uterine smooth muscle 
often affects contractions leading to abortions or preterm delivery, in 
some cases these contractions are quite strong and lead to foetal distress, 
hypoxia and often death.25,26 For the non-pregnant uterus (which was 
utilized in this study), contractions occur at different phases of the 
menstrual cycle; and are often referred to as spontaneous contractions. 
Focal and sporadic bulging of the myometrium,27,28 which causes 
sustained contractions as observed with high KCl in this study also 
occurs. These uterine contractions are necessary for endometrial 
sloughing 29 and also supports passage of sperm 30. Similar mechanisms 
of uterine contractility occur in late-term pregnancy with variations in 
the degree, as it does in the non-pregnant uterus, to systematically 
ensure successful expulsion of the foetus.30 This then implies that 
regardless of the presence or absence of pregnancy, uterine contractions 
are dependent on the contractile activity of the cellular elements, the 
uterine myocytes. The uterine myocytes are uterine smooth muscle cells 
which exhibit phasic pattern of contractility in a manner to maintain the 
resting tone. The resting tone is usually superimposed by intermittent 
sets of contractions with fluctuating frequency, amplitude and duration. 
Intracellular calcium concentration ([Ca2+]i) largely regulates this 
contractility 25,26 also referred to as spontaneous contractions. Green tea 
was observed in this study to inhibit these spontaneous uterine 
contractions at high concentrations which suggests an inhibition of the 
force and frequency of myocyte activity through [Ca2+]i inhibition.  An 
increase in  [Ca2+]i activates calcium ion (Ca2+)-dependent cytosolic 
protein, calmodulin (CalM).31 A Ca2+-CalM complex is formed which 
activates an enzyme, myosin light chain kinase (MLCK) causing an 
increase in myosin regulatory light chain-20 (MLC20) phosphorylation 
of and subsequent cross-bridge cycling.32 Phosphorylation of MLC20 
by MLCK is the principal determinant of the amplitude and duration of 
uterine contraction.33,34 The inhibitory effect of green tea was more 
evident with the frequency than the amplitude which may be attributed 
to a minimal effect of green tea on MLC20 phosphorylation. MLCK 
activation by CalM is considered a rate-limiting step of contraction 35 
and contributes to the contraction frequency of uterine smooth muscles. 
It would, therefore, appear that green tea may exert greater activity on 
MLCK activation and possibly a lesser effect on prevention of MLC20 
phosphorylation which affects the electrical activity within the uterus 
and may explain the differences in effect of green tea on the frequency 
and amplitude of uterine contraction.  
Green tea was also examined on OT-induced uterine contraction. 
Oxytocin is largely known to contract the uterine smooth muscle.30 
Calcium release and entry from the sarcoplasmic reticulum (SR) is 
augmented by OT. This is achieved by coupling of OT to its receptor 
which activates phospholipase-Cȕ, leading to the hydrolysis of 
phosphatidylinositol bisphosphate (PIP2) to release inositol 
triphosphate (IP3) and diacylglycerol (DAG).36 Intracellular calcium 
from the SR is activated by IP3 causing more opening of extracellular 
calcium channels.  DAG proceeds to activate protein kinase C36 all 
culminating in powerful uterine contractions.  The observed effect of 
green tea on oxytocin in this study supports the developing hypothesis 
that green tea may be involved in the prevention of MLCK activation. 
Interaction of green tea with IP3 and DAG is also hypothesized.  
KCl-rich solutions depolarize the cellular membrane of muscles 
resulting in contraction.37 Potassium±rich solutions alter the distribution 
of ions on myocyte membrane, activating an action potential which 
results in membrane depolarization and a markedly increased Ca2+ 
entry, with eventual contraction.38 7KHVHDFWLYLWLHVOHDGWRDµFRPSOH[
DFWLRQ SRWHQWLDO¶ FRQVLVWLQJ RI DQ LQLWLDO VSLNH-like depolarization 
followed by a sustained depolarization plateau and also involves strong 
conduction of Ca2+ 38 through voltage-operated calcium channels 
(VOCs), particularly the L-type calcium channel.39 Propagation of the 
action potentials through the uterine smooth muscle is coordinated by 
gap junctions within the myocytes prompting contraction synchronicity 
at the whole organ level.38,40 Several calcium channel blockers inhibits 
this mechanical response to high K+ via blockade of the L-type 
channels.41 This therefore suggests a mild interaction of green tea with 
VOCs which would have been responsible for the mild inhibition of 
KCl-induced contractions by green tea observed in this study. 
Several compounds were identified in green tea belonging to general 
classes of pteridines, cyclitols, flavonoids and coumarins. Some 
reported biological effects of some of the identified compounds are 
briefly discussed here in order to extrapolate possible relationship with 
the activity of green tea in this study. Pteridinedione belongs to the 
family of pteridines xanthopterin and are products of 
tetrahydrobiopterin degradation, a coenzyme utilized by aryl amino 
acid hydroxylases, glyceryl ether monooxidase and nitric oxide (NO) 
synthases.42 Pteridines have been reported to exhibit cytotoxic effects 
on a number of cancer cell lines.42,43 Pteridines have also been reported 
to inhibit NO production.43 The reported inhibition of NO production 
may contribute to the increased tension observed at lower 
concentrations of green tea in this study. In the presence of heat, HMF 
can be produced from sugars in plants which can then be enzymatically 
broken down to produce FCDA.44 This is a probable explanation for the 
detection of FCDA in green tea in this study. The biologic effect of 
FCDA is yet unknown and further studies are required to determine the 
effect of FCDA on uterine contractility. Hexahydroxyflavan and 
epicatechin are tannin flavonoids 45commonly found in tea and are 
members of the class of compounds known as catechins.46 Catechins 
are monomers of flavan-3-ol.47 Specifically, 3,3',4,4',5,7-
Hexahydroxyflavan is an epigallocatechin (ECG).47 Flavonoids are 
considered the main biologically active constituents of green tea47. 
Flavonoids are reported to inhibit activity of prostaglandins and NO48,49. 
Some flavonoids have been reported to inhibit lipoxygenase17 and NO 
synthase50 therefore preventing smooth muscle relaxation (stimulating 
contraction).  Flavonoids are also potent inhibitors of cyclic adenosine 
monophosphate phosphodiesterase and calcium dependent adenosine 
triphosphatase51 which prevents relaxation (stimulates contraction). 
However some flavonoids, inhibit cyclooxygenase enzyme 52 which can 
cause relaxation of muscles (inhibition). Catechins are also known to 
increase the level of hydrogen peroxide53 which is involved in several 
downstream signalling effect54 including inhibition of uterine smooth 
muscle contraction.55 Though catechins elevate cytosolic calcium, ECG 
is not known to do so56 which may also explain the inhibitory effect 
seen in this study. Further investigations on the role of ECG from green 
tea on uterine contractility are however suggested. In the same vein, 
kaempferol flavonoid which was also detected in green tea has been 
reported to increase cAMP production leading to inhibition of uterine  
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contractility 57,58 and may also contribute to the inhibitory effect of 
green tea on uterine contractions in this study. 
The compound, 3',4',5,7-tetrahydroxyflavone is a flavonoid also known 
as luteolin.59 It is known to inhibit protein kinase C,60 and 
lipoxygenase.61 Lipoxygenase enzymes promote the breakdown of 
arachidonic acid into leukotrienes which interact with their receptors 
leading to calcium mobilization and uterine contraction.62 Therefore 
inhibition of these enzymes can lead to uterine smooth muscle 
relaxation.63 Luteolin is also reported to interact with gamma amino 
butyric acid (GABA) A receptors64 which are well known to inhibit 
smooth muscle contraction65. Luteolin has also been reported to reduce 
the L-type calcium current of rat ventricular myocytes.66 These reports 
suggest luteolin to be one of the active inhibitory constituents of green 
tea.  
Quinic acid is a cyclic polyol and has been reported to produce phenolic 
acid derivatives.67 Quinic acid has been reported to inhibit Nuclear 
Factor-kappa B (NF-ț%E\LQFUHDVLQJWKHSURGXFWLRQRIQLFRWLQDPLGH
and tryptophan.68 However, an increase in nicotinamide has been shown 
to be positively correlated to the activity of OT in stimulating uterine 
contractions69 suggesting a contraction stimulatory role for quinic acid 
and may not contribute to the inhibitory effect of green tea at higher 
concentrations in this study. 
Sedoheptulose is a seven-carbon ketose sugar originally found in Sedum 
spectabile and can also be found as part of the human diet.70 It is 
involved in the cyclic regeneration of d-ribulose where it acts as an 
intermediary compound. It is also involved in ribulose regeneration in 
plant photosynthesis.70 The compound has been reported to prevent or 
delay diabetes onset,71 but there appears to be no report on its 
involvement in uterine contractility. 
Kaempferol and myricetin which were also detected in this study had 
been previously reported as two of the three main flavanols in tea.72 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Kaempferol has been reported to induce uterine relaxation in rats57 and 
may play a role in the inhibitory effect of green tea. Though there have 
been no reports on myricetin on uterine contractility, myricetin and 
kaempferol have been shown to exert oestrogenic effect on the uterus 
as observed in the uterine hypertrophy induced.73-74 Though oestrogenic 
effect does not directly determine effects on contractility, the similarity 
between myricetin and kaempferol suggests they may both exert similar 
effects on uterine contractility. 
The interaction of the different metabolites found in green tea are seen 
to have potential effects on uterine contraction, while for others like 
kaempferol there are scientific reports to show its inhibitory effect on 
uterine contractility, all of which contribute to the inhibitory effect of 
green tea observed. 
 
Conclusion 
This study reports the inhibitory effect of green tea extract on uterine 
contractility. Green tea extract was shown in this study to inhibit 
spontaneous, oxytocin- and high KCl-induced uterine contractions.  
Possible interaction with prostaglandins and voltage-gated calcium 
channels are suggested. In addition, possible prevention of MLCK 
activation and interaction of green tea with IP3 and DAG are also 
suggested. However these possibilities require further investigation. 
Several secondary metabolites were also identified in the green tea 
extract which was found to include pteridines, cyclitols, flavonoids and 
coumarins. Since the study was done using the non-pregnant uterus, it 
can be inferred that green tea consumption by females may contribute 
to easing uterine contraction which often leads to hyperalgesia during 
menstruation. Studies on the pregnant uterus are additionally 
recommended in order to gain an insight into what green tea does on the 
pregnant uterus. 
Table 1: Putatively Identified Compounds in Green Tea. 
 
S/N Compound name 
Molecular 
formula 
Molecular weight 
(g/mol) m/z Rt (min) 
1. 2,4(1H,3H)-Pteridinedione C8H8N4O2 192.0650 [M-H]- 191.0577 1.07 
2. Quinic acid C7H12O6 192.0635 [M-H]- 191.0562 1.19 
3. 2,4-Furandicarboxylic acid C7H6O5 170.0217 [M-H]- 169.0144 1.30 
4. Epicatechin C15H14O6 290.0787 [M-H]- 289.0714 2.06 
5. Quinic acid; (-)-form, 3-O-(3,4,5-
Trihydroxybenzoyl) 
C14H16O10 344.0741 [M-H]- 343.0668 2.15 
6. 1,7-Di-O-galloyl-D-sedoheptulose C21H22O15 514.0959 [M-H]- 513.0880 2.24 
7. 3-O-Galloylquinic acid C14H16O10 344.0743 [M-H]- 343.0669  
2.85 
8. 1,2-Digalloylglucose C20H20O14 484.0853 [M-H]- 483.0767 3.49 
9. 3,3',4',5,5',7-Hexahydroxyflavan;  (2R,3S)-form C15H14O7 306.0732 [M-H]- 305.0660 3.70 
10. 1-O-Caffeoyl-4-deoxyquinic acid C16H18O8 338.1002 [M-H]- 337.0923 3.85 
11. Luteolin- 3'-O-(3-O-Acetyl-ȕ-D-
glucuronopyranoside) 
C23H20O13 504.0904 [M-H]- 503.0816 4.83 
12. 3-O-Galloylepigallocatechin C22H18O11 458.0847 [M+H]+ 459.0920 4.85 
13. 3-O-Galloylepigallocatechin C22H18O11 458.0849 [M-H]- 457.0766 5.07 
14. Myricetin 3-glucoside C21H20O13 480.0904 [M-H]- 479.0823 5.25 
15. Kaempferol 3-diglycosides; 3-O->ȕ-D-
Galactopyranosyl-ĺ-ȕ-D-glucopyranoside] 
C27H30O16 610.1535 [M-H]- 609.1462 5.58 
16. 8-C-Glucosylapigenin C21H20O10 432.1056 [M-H]- 431.0981 5.61 
17. Isotrifolin C21H20O12 464.0954 [M-H]- 463.0879 5.97 
18. 3,3',4',5,7-Pentahydroxyflavan C22H18O10 442.0900 [M-H]- 441.0827 6.10 
19. 3'-Galloylcatechin C22H18O10 442.0900 [M-H]- 441.0822 6.52 
20. Kaempferol 7-glucoside C21H20O11 448.1006 [M-H]- 447.0929 6.98 
21. Dihydroxyflavone C15H10O4 254.0579 [M+H]+255.0649 11.71 
22. Dinonyl phthalate  
(plasticizer, artefact) 
C26H42O4 418.3083 [M+H]+419.3156 14.52 
23. 6'-O-Angeloy marmin C24H30O6 414.2042 [M+H]+415.2114 17.05 
  
 
Table 2: Unidentified Compounds in Green Tea Extract. 
 
Predicted 
Molecular formula 
Double bond 
equivalence 
Molecular weight 
(g/mol) m/z Rt (min) 
24. C35H24O2 24.0 476.1776 [M+H]+477.1867 3.87 
25. C23H14N2O10 18.0 478.0664 [M-H]- 477.0591 6.13 
                  Double bond equivalence (DBE) indicates number of rings and double bonds in the structure where 1 ring = 1 DBE 
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Figure 1: Effect of green tea (GT) extracts on spontaneous uterine contraction. (A). Original recording showing the effect of GT on 
spontaneous uterine contractility. (B). Concentration response-curve showing the effect of GT on the amplitude of spontaneous uterine 
contraction. (C) Concentration response-curve showing the effect of GT on the frequency of spontaneous uterine contraction. n= 5 
animals. 
 
 
 
Figure 2: Effect of green tea (GT) extracts on oxytocin (OT)-induced uterine contraction. (A) Original recording showing the effect of 
GT on OT-induced spontaneous uterine contractility. (B) Bar graph showing the effect of GT on the amplitude of OT-induced uterine 
contraction (C) Bar graph showing the effect of GT on the frequency of OT-induced uterine contraction. **P > 0.001; n= 5 animals.   
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Figure 3: Effect of green tea (GT) extracts on high KCl-induced uterine contraction (80 mM). (A) Original recording showing the effect 
of GT on high KCl-induced uterine contraction. (B) Bar graph showing the effect of GT on the amplitude of KCl-induced uterine 
contraction. n= 5 animals.  
  
 
 
 
 
Figure 4: Total ion chromatogram for GT in A) negative and B) positive ionisation modes showing identified metabolites (1-23) and 
unidentified but detected metabolites (24 and 25).  The identification, molecular formula, molecular weight, mass to charge ratio (m/z) 
and retention time in min (RT) are indicated in tables 1 and 2.  
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